{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 0.0, "regularMarketPrice": 7.4, "exchange": "FRA", "shortName": "PHARVARIS N.V.  EO -,12", "longName": "Pharvaris N.V.", "messageBoardId": "finmb_402951024", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "marketState": "REGULAR", "esgPopulated": false, "priceEpsCurrentYear": -2.9133859, "sharesOutstanding": 33816500, "bookValue": 4.414, "fiftyDayAverage": 7.385, "fiftyDayAverageChange": 0.0149998665, "fiftyDayAverageChangePercent": 0.002031126, "twoHundredDayAverage": 8.12325, "twoHundredDayAverageChange": -0.7232499, "twoHundredDayAverageChangePercent": -0.08903455, "marketCap": 261419056, "forwardPE": -2.5342464, "priceToBook": 1.6764839, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Pharvaris B.V.", "nameChangeDate": "2023-05-11", "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1613458800000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683871501, "regularMarketDayHigh": 7.4, "regularMarketDayRange": "7.4 - 7.4", "regularMarketDayLow": 7.4, "regularMarketVolume": 1030, "regularMarketPreviousClose": 7.4, "bid": 7.45, "ask": 7.7, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 7.4, "averageDailyVolume3Month": 17, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 5.53, "fiftyTwoWeekLowChangePercent": 2.9572194, "fiftyTwoWeekRange": "1.87 - 25.8", "fiftyTwoWeekHighChange": -18.4, "fiftyTwoWeekHighChangePercent": -0.7131783, "fiftyTwoWeekLow": 1.87, "fiftyTwoWeekHigh": 25.8, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.26, "epsForward": -2.92, "epsCurrentYear": -2.54, "symbol": "9EN.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Emmy Noetherweg 2", "city": "Leiden", "zip": "2333 CH", "country": "Netherlands", "phone": "31 71 203 6410", "website": "https://pharvaris.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.", "fullTimeEmployees": 65, "companyOfficers": [{"maxAge": 1, "name": "Mr. Berndt Axel Edvard Modig CPA, M.B.A., MBA", "age": 63, "title": "Co-Founder, CEO & Exec. Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 500000, "fmt": "500k", "longFmt": "500,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anna  Nijdam M.Sc., R.A.", "age": 41, "title": "Head of Fin. & Principal Accounting Officer", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jochen  Knolle Ph.D.", "age": 72, "title": "Chief Scientific Officer & COO", "yearBorn": 1950, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Joan  Schmidt J.D.", "age": 58, "title": "Chief Legal Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peng  Lu M.D., Ph.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anne  Lesage Ph.D.", "age": 61, "title": "Chief Early Devel. Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Morgan  Conn Ph.D.", "age": 53, "title": "Chief Bus. Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wim  Souverijns Ph.D.", "age": 51, "title": "Chief Community Engagement & Commercial Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Maryann  Cimino", "title": "Director of Corp. Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Annick  Deschoolmeester", "age": 49, "title": "Chief HR Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}